Proteomic Analysis of Huntington's Disease

Area of Science:

• Neurogenetics
• Neurodegenerative Diseases
• Molecular Biology

Background:

• Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disorder.
• Caused by a CAG nucleotide repeat expansion in the HD gene on chromosome 4, leading to polyglutamine tracts.
• The precise pathogenesis of polyglutamine expansion in HD remains unclear.

Purpose of the Study:

• To review proteomic analysis methods for investigating HD gene mutations.
• To highlight the role of proteomics in understanding HD molecular changes.
• To enhance the effectiveness of Huntington's disease treatments.

Main Methods:

• Proteomic analysis techniques including mass spectroscopy, gel electrophoresis, and western blotting.
• Chromatographic based technologies.
• X-ray crystallography for structural analysis.

Main Results:

• Proteomic analysis can identify and investigate mutations in the HD gene.
• Focusing on molecular alterations in HD through proteomics is crucial.
• Understanding these molecular changes can lead to more effective therapeutic strategies.

Conclusions:

• Proteomic investigations are vital for dissecting the molecular underpinnings of Huntington's disease.
• This approach holds significant potential for developing targeted and effective treatments.
• Further research utilizing proteomic strategies is recommended for advancing HD patient care.